FIELD: medicine, oncology. SUBSTANCE: the suggested method includes, at least, one seance of radiation therapy, and/or, at least, one seance of chemotherapy. Also, before and/or after seance of radiation therapy and/or, at least, before and/or after one seance of chemotherapy one should carry out, at least, one seance of irradiation with electromagnetic radiation. Irradiation is carried out simultaneously at frequency chosen in the range of 43-47 MHz and at frequency chosen in the range of 568-592 MHz, and/or simultaneously at frequency chosen in the range of 88-922 MHz and at frequency chosen in the range of 478-482 MHz, and/or simultaneously at frequency chosen in the range of 115-120 MHz and at frequency chosen in the range of 1104-1148 MHz, and/or simultaneously at frequency chosen in the range of 144-148 MHz and at frequency chosen in the range of 208-216 MHz, and/or simultaneously at frequency chosen in the range of 208- 216 MHz and at frequency chosen in the range of 940-978 MHz, and/or simultaneously at frequency chosen in the range of 274-286 MHz and at frequency chosen in the range of 537-559 MHz, and/or simultaneously at frequency chosen in the range of 301-313 MHz and at frequency chosen in the range of 416-433 MHz, and/or simultaneously at frequency chosen in the range of 478- 482 MHz and at frequency chosen in the range of 1245- 1295 MHz, and/or simultaneously at frequency chosen in the range of 447-465 MHz and at frequency chosen in the range of 568-592 MHz, and/or simultaneously at frequency chosen in the range of 537-559 MHz and at frequency chosen in the range of 706-736 MHz, and/or simultaneously at frequency chosen in the range of 940- 978 MHz and at frequency chosen in the range of 1554- 1618 MHz. Moreover, irradiation should be conducted at modulation frequency within 4-200 Hz, and flow density of electromagnetic radiation power in place of patient's location should be established to be not more than 10 mcW/sq. cm. The method enables to achieve effect of anesthetization, deterioration of inflammatory processes, correction of affected immune status, cellular lysis of necrotic tissues. EFFECT: higher efficiency of therapy.
Title | Year | Author | Number |
---|---|---|---|
METHOD AND DEVICE FOR APPLYING PHYSIOTHERAPEUTIC TREATMENT | 2001 |
|
RU2203702C1 |
METHOD AND DEVICE FOR ACTING UPON BIOLOGICAL OBJECTS | 1999 |
|
RU2155084C1 |
METHOD OF EXPERIMENTAL TREATMENT OF MALIGNANT NEOPLASMS | 2004 |
|
RU2286811C2 |
METHOD FOR TREATMENT OF MALIGNANT NEOPLASMS USING ELECTROMAGNETIC INFLUENCES IN EXPERIMENT | 2004 |
|
RU2289446C2 |
METHOD FOR PREVENTING AND TREATING ORAL MUCOSITIS IN CHILDREN DEVELOPING WITH UNDERLYING HIGH-DOSE CHEMORADIATION THERAPY | 2018 |
|
RU2692448C1 |
METHOD FOR TREATING PATIENTS WITH TOPICALLY METASTASING PHARYNGEAL CANCER | 2005 |
|
RU2289364C1 |
METHOD FOR DESTROYING MALIGNANT NEOPLASMS | 1993 |
|
RU2034548C1 |
METHOD OF NEOADJUVANT THERMOCHEMORADIATION TREATMENT OF RECTAL CANCER | 2018 |
|
RU2704205C2 |
METHOD FOR PREVENTION OF DEVELOPING RADIATION REACTIONS IN PATIENTS WITH CERVICAL CANCER | 2014 |
|
RU2562447C1 |
METHOD FOR REMOTE ELECTROMAGNETIC MULTIWAVE RADIO NEUROENGINEERING OF HUMAN BRAIN | 2015 |
|
RU2621547C2 |
Authors
Dates
2003-08-10—Published
2001-07-12—Filed